February 11, 2021 Hope grows for blood cancer patients, as cell therapy firm’s key trial succeeds View Article
January 28, 2021 Ayala Pharmaceuticals Announces First Patient Dosed in Phase 2 TENACITY Clinical Trial of AL101 for the Treatment of Patients with Notch-Activated Triple Negative Breast Cancer View Article
January 12, 2021 Alpha Tau Medical Announces Appointment of Peter Melnyk as New Board Member View Article
December 22, 2020 PolyPid Announces Positive Preclinical Data from OncoPLEX Intra-Tumoral Cancer Therapy Program View Article
December 21, 2020 Gamida Cell Announces Closing of $75 Million Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares View Article
December 21, 2020 Mapi Pharma Provides Enrollment Update in Phase III GA Depot Clinical Trial View Article
December 16, 2020 PolyPid Initiates SHIELD II: Second Phase 3 Clinical Trial of D-PLEX₁₀₀ for the Prevention of Post-Abdominal Surgery Incisional Infections View Article
